Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC.NUS · Entity 6223 | Director · President and CEO | March 06, 2026 | March 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NU SKIN ENTERPRISES, INC.
Report date March 06, 2026 · Filed March 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,001,905 |
Reported balance
After 2026-03-06 transaction · row 1
1 source rowRow 1 · 2026-03-06 · Grant · Acquired 282,353 · Balance 1,001,905 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 9, 2026 22:06 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 282,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-26-000032 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,001,905 Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:35 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 124,802 | $8.63 | $1,077,041.26 |
DisclosureSEC source: 0001021561-26-000022 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 719,552 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:28 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 49,037 | $8.36 | $409,949.32 |
DisclosureSEC source: 0001021561-26-000012 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 844,354 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 23:07 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 206,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-26-000002 · form4.xml · nonDerivative · entry 2 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 893,391 F2 · shares: On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 23:07 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 42,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-26-000002 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 686,403 F1 · shares: On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 21:40 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 310,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003788 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 643,433 Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:24 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 40,857 | $7.56 | $308,878.92 |
DisclosureSEC source: 0001062993-25-002882 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,954 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:29 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 17,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002532 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,811 F1 · shares: On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 12, 2025, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 22:33 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 189,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004813 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,117 Read SEC document |
| February 15, 2024 Filed Feb 21, 2024 01:14 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 12,573 | $13.82 | $173,758.86 |
DisclosureSEC source: 0001062993-24-003757 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,543 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 13, 2024 Filed Feb 14, 2024 23:06 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 10,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-003190 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,116 F1 · shares: On February 22, 2023, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 13, 2024, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:46 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · derivative · entry 8 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 10,000 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:46 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 600 | $40.97 | $24,582.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · nonDerivative · entry 5 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,784 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.91 to $41.02, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:46 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 9,400 | $40.38 | $379,572.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · nonDerivative · entry 4 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,384 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.89 to $40.86, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:46 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 10,000 | $30.63 | $306,300.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · nonDerivative · entry 3 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:46 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · derivative · entry 7 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 19,000 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:46 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,513 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · derivative · entry 6 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 2,513 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:46 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 21,513 | $41.38 | $890,207.94 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · nonDerivative · entry 2 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,784 F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.85 to $41.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:46 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 21,513 | $30.63 | $658,943.19 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 22:47 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 53,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004616 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,784 Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 23:09 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 6,963 | $45.38 | $315,980.94 |
DisclosureSEC source: 0001062993-23-003820 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,720 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:09 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (Right to Buy) · Derivative | 37,751 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-003820 · form4.xml · derivative · entry 2 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,831 Underlying: Class A Common Stock · 37,751 shares Expires 2027-02-15 F2 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 14, 2023, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 21:48 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-22-022820 · form4.xml · derivative · entry 5 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Underlying: Class A Common Stock · 13,000 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 21:48 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $37.58 | $0.00 |
DisclosureSEC source: 0001062993-22-022820 · form4.xml · derivative · entry 4 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 12,000 shares Expires 2022-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 21:48 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 25,000 | $38.45 | $961,250.00 |
DisclosureSEC source: 0001062993-22-022820 · form4.xml · nonDerivative · entry 3 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,683 F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.02 to $38.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 21:48 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 13,000 | $30.63 | $398,190.00 |
DisclosureSEC source: 0001062993-22-022820 · form4.xml · nonDerivative · entry 2 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2022 Filed Nov 28, 2022 21:48 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 12,000 | $37.58 | $450,960.00 |
DisclosureSEC source: 0001062993-22-022820 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2022 Filed Aug 25, 2022 22:36 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-22-018768 · form4.xml · derivative · entry 6 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Class A Common Stock · 12,000 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| August 25, 2022 Filed Aug 25, 2022 22:36 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $37.58 | $0.00 |
DisclosureSEC source: 0001062993-22-018768 · form4.xml · derivative · entry 5 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Class A Common Stock · 13,000 shares Expires 2022-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| August 25, 2022 Filed Aug 25, 2022 22:36 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 12,749 | $43.22 | $551,011.78 |
DisclosureSEC source: 0001062993-22-018768 · form4.xml · nonDerivative · entry 4 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,683 F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.02 to $43.41, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| August 25, 2022 Filed Aug 25, 2022 22:36 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 12,251 | $42.76 | $523,852.76 |
DisclosureSEC source: 0001062993-22-018768 · form4.xml · nonDerivative · entry 3 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,432 F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.02 to $43.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| August 25, 2022 Filed Aug 25, 2022 22:36 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 12,000 | $30.63 | $367,560.00 |
DisclosureSEC source: 0001062993-22-018768 · form4.xml · nonDerivative · entry 2 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2022 Filed Aug 25, 2022 22:36 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 13,000 | $37.58 | $488,540.00 |
DisclosureSEC source: 0001062993-22-018768 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:45 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-22-013608 · form4.xml · derivative · entry 6 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Class A Common Stock · 12,000 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:45 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $37.58 | $0.00 |
DisclosureSEC source: 0001062993-22-013608 · form4.xml · derivative · entry 5 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 13,000 shares Expires 2022-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:45 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 15,548 | $45.13 | $701,681.24 |
DisclosureSEC source: 0001062993-22-013608 · form4.xml · nonDerivative · entry 4 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,683 F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.85 to $45.37, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:45 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 9,452 | $44.55 | $421,086.60 |
DisclosureSEC source: 0001062993-22-013608 · form4.xml · nonDerivative · entry 3 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,231 F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.85 to $44.84, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:45 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 12,000 | $30.63 | $367,560.00 |
DisclosureSEC source: 0001062993-22-013608 · form4.xml · nonDerivative · entry 2 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:45 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 13,000 | $37.58 | $488,540.00 |
DisclosureSEC source: 0001062993-22-013608 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:51 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,200 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-22-006161 · form4.xml · derivative · entry 7 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Class A Common Stock · 6,200 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:51 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 18,800 | $0.00 Strike: $37.58 | $0.00 |
DisclosureSEC source: 0001062993-22-006161 · form4.xml · derivative · entry 6 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Class A Common Stock · 18,800 shares Expires 2022-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:51 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 7,253 | $47.70 | $345,968.10 |
DisclosureSEC source: 0001062993-22-006161 · form4.xml · nonDerivative · entry 5 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,683 F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.61 to $47.83, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:51 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 17,747 | $47.28 | $839,078.16 |
DisclosureSEC source: 0001062993-22-006161 · form4.xml · nonDerivative · entry 4 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,936 F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.61 to $47.60, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:51 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 6,200 | $30.63 | $189,906.00 |
DisclosureSEC source: 0001062993-22-006161 · form4.xml · nonDerivative · entry 3 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:51 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 18,800 | $37.58 | $706,504.00 |
DisclosureSEC source: 0001062993-22-006161 · form4.xml · nonDerivative · entry 2 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:51 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 31,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006161 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,683 Read SEC document |
| February 15, 2022 Filed Feb 18, 2022 02:36 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 4,498 | $49.65 | $223,325.70 |
DisclosureSEC source: 0001062993-22-004838 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,070 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 21:38 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (Right to Buy) · Derivative | 21,883 | $0.00 Strike: $48.81 | $0.00 |
DisclosureSEC source: 0001062993-22-004461 · form4.xml · derivative · entry 2 NAPIERSKI RYAN S · CIK 0001652984 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,883 Underlying: Class A Common Stock · 21,883 shares Expires 2028-02-15 F2 · shares: On February 15, 2021, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 21:38 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (Right to Buy) · Derivative | 70,540 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-22-004461 · form4.xml · derivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,080 Underlying: Class A Common Stock · 70,540 shares Expires 2027-02-15 F1 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 21:07 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 13,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-008101 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,568 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.